WuXi Apptech

News  |  www.wuxiapptec.com | Jan 14, 2009

R & D services are provided by WuXi AppTec, a fully integrated pharmaceutical, biotechnology and medical device R&D services company.

http://www.wuxiapptec.com/

Novartis Oncology Global Website - Online Resources: Cancer Causes, Treatments & Strategies

Disclaimer: This site is intended to provide information to audiences outside the United States. Please note that not all products listed within this site may be available in all countries.

http://www.novartisoncology.com/

Drug development for neglected diseases: a deficient market and a public-health policy failure :

News  |  www.thelancet.com

Drug development for neglected diseases: a deficient market and a public-health policy failure. By - Dr Patrice Trouiller PharmD, Piero Olliaro PhD, Els Torreele PhD, James Orbinski MD, Richard Lai...

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)09096-7

Millipore

News  |  www.millipore.com | Mar 2, 2009

Advancing Life Science Together - Bioscience research, Biopharmaceutical manufacturing - Millipore broad range of Life Science tools, technologies, and services make it possible for us to create personalized solutions to industry challenges and assure scientific success

http://www.millipore.com/

Viva Pharmaceutical - Home

Viva Pharmaceutical was the Silver Sponsor for the Chinese Federation of Commerce of Canada Fundraising Gala 2009 for 2381 BCR (Irish Fusiliers) Royal Canadian Army Cadet Corps. The dinner was held on May 16th, 2009 at Radisson Hotel Vancouver Airport.

http://www.vivapharm.com/

Drug Discovery & Development

News  |  www.dddmag.com

Fresh results from the world's first successful test of an experimental AIDS vaccine confirm that it is only marginally effective and suggest that its protection against HIV infection may wane over time.

http://www.dddmag.com/articles.aspx?id=3272&menuid=&lm=5&page=5

Stegmann Systems GmbH

News  |  www.drugdevelopment-technology.com | Jan 8, 2008

Alemtuzumab – Potential in Multiple Sclerosis Alemtuzumab (Campath/MabCampath) is an anti-CD52 monoclonal antibody (MAb) for which Bayer HealthCare holds exclusive global...

http://www.drugdevelopment-technology.com/

Atlanta Research Center

The Atlanta Research Center s specialty is in the development of investigational drug therapies for osteoporosis, specifically in postmenopausal women. All our studies are funded by research grants from pharmaceutical company sponsors.

http://www.arcenter.net/

Wyeth (Singapore) PteLimited in Singapore, Singapore

Company  |  chemicals.zibb.com | Apr 29, 2009

Wyeth (Singapore) PteLimited, Singapore, , Singapore, Food Processors or Products, Healthcare Preparations or Products, Medicines and Medical Drugs, Pharmaceutical Distributors or Agents, Pharmaceutical Manufacturers or Contract Manufacturing

http://chemicals.zibb.com/profile/wyeth+(singapore)+ptelimited/sg/singapore/238164/26214782

New Data for Investigational Diabetes Drug Saxagliptin Demonstrates Potential for Type 2 Diabetes Treatment

News  |  www.astrazenecaevents.com | Sep 9, 2008

AstraZeneca corporate information, one of the world's leading pharmaceutical companies providing effective prescription drugs and innovative prescription medicines in many important therapeutic areas

http://www.astrazenecaevents.com/